📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.

Bio-Techne Corp

Common Name
Bio-Techne
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
3,100
Ticker
TECH
Exchange
NASDAQ/NGS
Description
Bio-Techne Corporation is a leading developer and manufacturer of high-quality biological products and solutions for the research and clinical diagnostic markets. The company specializes in providing ...

Bio-Techne's GHG Emissions Data Preview

In 2023, Bio-Techne completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Bio-Techne has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Location-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Data
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=TECH&reporting_period=2024"

Verified Sources Behind Bio-Techne’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Bio-Techne’s data sources below and access millions more through our Disclosure Search.

a. Bio-Techne's Sustainability Report 2024
a. Bio-Techne's Sustainability Report 2024

Insights into Bio-Techne's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions ofBio-Techne amounted to17,566metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2022, the total operational greenhouse gas (GHG) emissions of Bio-Technedecreased by 0.15%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a

Bio-Techne's Scope 1 Emissions Over Time

20212022202309501.9 k2.85 k3.8 ktCO2e+41%-21%
  • Total Scope 1
  • Year-over-Year Change

What are Bio-Techne's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Bio-Techne were 3,001 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a

Has Bio-Techne reduced its Scope 1 emissions over time?

Since 2021, Bio-Techne's Scope 1 emissions have increased by 11.81%, reflecting a rising long-term trend in Scope 1 emissions over time.a

Compared to the previous year(2022), Bio-Techne's Scope 1 emissions decreased by 20.63%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a

What are Bio-Techne's Scope 2 emissions?

In 2023, Bio-Techne reported Scope 2 greenhouse gas (GHG) emissions of 14,565 tCOâ‚‚e using the location-based method.a

Has Bio-Techne reduced its Scope 2 emissions over time?

Since 2021, Bio-Techne's Scope 2 greenhouse gas (GHG) emissions (Location-Based)have increased by 14.74%, reflecting a rising long-term trend in Scope 2 emissions over time.a

Compared to the previous year(2022), Bio-Techne's Scope 2 emissions(Location-Based) have remained relatively stable, indicating that Bio-Techne's emissions have plateaued with no significant change in its energy consumption footprint.a

What methodology does Bio-Techne use for Scope 2 reporting?

In 2023, Bio-Techne reported its Scope 2 emissions using the location-based method.a

Bio-Techne's Scope 2 Emissions Over Time

20212022202304 k8 k12 k16 ktCO2e
  • Total Scope 2 Location-Based

Insights into Bio-Techne’s GHG Emissions Intensity Compared to Industry Peers

In 2023, Bio-Techne reported Scope 1 greenhouse gas (GHG) emissions of 3,001 tCOâ‚‚e and total revenues of USD 1,137 millions. This translates into an emissions intensity of 2.64 tCOâ‚‚e per millions USD.a

Bio-Techne's Scope 1 Emissions Intensity Compared to Peers

2501,00010,000200,000Scope 1 Emissions (tCO2e)101005005,00050,000Revenues (Millions of USD)FARCIncyteYear: 2024Scope 1: 9,576 tCO2eRevenue: $M 4,241Scope 1 Intensity: 2.26 tCO2e/$MInsmedYear: 2024Scope 1: 1,666 tCO2eRevenue: $M 364Scope 1 Intensity: 4.58 tCO2e/$MInsuletYear: 2024Scope 1: 1,383 tCO2eRevenue: $M 2,072Scope 1 Intensity: 0.67 tCO2e/$MLegend BiotechYear: 2024Scope 1: 769 tCO2eRevenue: $M 627Scope 1 Intensity: 1.23 tCO2e/$MFFFortrea HoldingsYear: 2023Scope 1: 864 tCO2eRevenue: $M 3,109Scope 1 Intensity: 0.28 tCO2e/$MExact SciencesYear: 2024Scope 1: 12,121 tCO2eRevenue: $M 2,759Scope 1 Intensity: 4.39 tCO2e/$MFrontage HoldingsYear: 2023Scope 1: 2,883 tCO2eRevenue: $M 2,027Scope 1 Intensity: 1.42 tCO2e/$MWest Pharmaceutical ServicesYear: 2024Scope 1: 31,327 tCO2eRevenue: $M 2,893Scope 1 Intensity: 10.83 tCO2e/$MRegeneron PharmaceuticalsYear: 2024Scope 1: 80,300 tCO2eRevenue: $M 14,202Scope 1 Intensity: 5.65 tCO2e/$MHalozyme TherapeuticsYear: 2024Scope 1: 1,348 tCO2eRevenue: $M 1,015Scope 1 Intensity: 1.33 tCO2e/$MModernaYear: 2024Scope 1: 13,180 tCO2eRevenue: $M 3,199Scope 1 Intensity: 4.12 tCO2e/$MSarepta TherapeuticsYear: 2023Scope 1: 3,428 tCO2eRevenue: $M 1,243Scope 1 Intensity: 2.76 tCO2e/$MWatersYear: 2023Scope 1: 12,660 tCO2eRevenue: $M 2,956Scope 1 Intensity: 4.28 tCO2e/$MAAAmneal PharmaceuticalsYear: 2024Scope 1: 40,500 tCO2eRevenue: $M 2,794Scope 1 Intensity: 14.50 tCO2e/$MRRRevvityYear: 2024Scope 1: 2,468 tCO2eRevenue: $M 2,755Scope 1 Intensity: 0.90 tCO2e/$MCytokineticsYear: 2024Scope 1: 242 tCO2eRevenue: $M 18Scope 1 Intensity: 13.10 tCO2e/$MAlnylam PharmaceuticalsYear: 2024Scope 1: 3,832 tCO2eRevenue: $M 2,248Scope 1 Intensity: 1.70 tCO2e/$MCCCatalyst PharmaceuticalsYear: 2024Scope 1: 4 tCO2eRevenue: $M 493Scope 1 Intensity: 0.01 tCO2e/$MEnvista HoldingsYear: 2024Scope 1: 3,000 tCO2eRevenue: $M 2,511Scope 1 Intensity: 1.19 tCO2e/$MBioMarin PharmaceuticalYear: 2022Scope 1: 14,000 tCO2eRevenue: $M 2,096Scope 1 Intensity: 6.68 tCO2e/$MIonis PharmaceuticalsYear: 2024Scope 1: 2,616 tCO2eRevenue: $M 705Scope 1 Intensity: 3.71 tCO2e/$MVertex PharmaceuticalsYear: 2024Scope 1: 8,976 tCO2eRevenue: $M 11,020Scope 1 Intensity: 0.81 tCO2e/$MBio-TechneYear: 2023Scope 1: 3,001 tCO2eRevenue: $M 1,137Scope 1 Intensity: 2.64 tCO2e/$M

How does Bio-Techne's GHG emissions intensity compare to its peers?

In 2023, Bio-Techne reported a Scope 1 emissions intensity of 2.64 tCOâ‚‚e per millions USD. Compared to the peer group median of 2.51, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a

Where does Bio-Techne rank on GHG emissions intensity within its industry?

In 2023, Bio-Techne ranked 12 out of 22 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a

Bio-Techne is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a

Want Full Access to Bio-Techne's GHG Emissions Dataset?
Sign Up